Daicel
The best two choices for orally disintegrating tablets
In pharmaceutical business fields, patient-centric formulation is one of the areas Daicel focuses on and we have been developing new excipients using our technologies. Here we offer the best two choices for orally disintegrating tablets (ODTs).
产品在formation
HiSORADTM:NewDirectly compressible excipient for ODTs
Product Features
- HiSORAD is a state-of-the-art co-processed excipient for ODTs designed to have well-balanced property between oral disintegration time and tablet hardness.
- HiSORAD realizes high tablet hardness possible even at relatively low compression forces. Tableting of poorly compressible APIs may be possible due to its excellent compactibility.
- Ingredients: three compendial grade excipients: Mannitol, Microcrystalline Cellulose and Croscarmellose sodium.
- Regulatory status: DMF under preparation
Characteristics
- Excellent compactibility
- Well-balanced tablet property between OD time and hardness
- High API loading capacity
- Simple composition
Tablet properties (Placebo)
- High tablet hardness possible even at relatively low compression forces
- Placebo tablet with HiSORAD draws water rapidly and disintegrates within 20 seconds.
Composition:HSR-D03 (99.5%) + Ca Stearate (0.5%)
Tableting Condition:Rotary-press, 20 rpm, Open-Feeder
Hardness:Measured by electronic hardness tester (Ave. of n=10)
Friability:Measured by JP general test method
Tablet Shape:200 mg, φ8 mm, Flat-bevelled edge
Disintegration Time:Measured by JP general test method (D.T.) (Ave. of n=6)
Oral Disintegration Time:Measured by Tricorptester (Ave. of n=6)
(O.D.T) (Okada Seiko Co., Ltd. Tokyo, Japan)
GRANFILLER-DTM: Directly compressible excipient for ODTs
Product Features
- GRANFILLER-D is a co-processed excipient intended for preparing Orally Disintegrating Tablets (ODTs). It is designed to achieve rapid disintegration while maintaining high tablet hardness.
- Ingredients: four compendial grade excipients: Mannitol, Microcrystalline Cellulose, Carmellose and Crospovidone.
- Regulatory status: Listed in JPE2018, US-DMF and China-DMF filed.
Characteristics
- Well-balanced tablet property between OD time and hardness
- High API loading capacity
- Excellent content uniformity
- Compatible with various excipients
DOWNLOAD BROCHURE OF GRANFILLER-D
Whitepapers:
Contact
Daicel Excipients
生命科学业务Division
DAICEL CORPORATION
2-18-1, Konan, Minato-ku, Tokyo, 108-8230, Japan